Table 4.
Responses to Bristol female urinary tract symptoms questionnaire before and six months after tension-free vaginal tape procedure or colposuspension. Unless stated otherwise, values are numbers (percentages) of all patients reporting individual symptoms and for those reporting symptoms as bit of a problem, quite a problem, or serious problem
| Symptom
|
Vaginal tape group
|
Colposuspension group
|
P value*
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before surgery (n=168)
|
6 months postoperatively (n=159)
|
Before surgery (n=154)
|
6 months postoperatively (n=127)
|
Reporting symptom
|
Reporting symptom as problem
|
||||||||
| Reporting symptom
|
Reporting symptom as problem
|
Reporting symptom
|
Reporting symptom as problem
|
Reporting symptom
|
Reporting symptom as problem
|
Reporting symptom
|
Reporting symptom as problem
|
||||||
| Urinary symptoms: | |||||||||||||
| Daytime frequency (>7)† | 134 (80) | 128 (76) | 78 (49) | 33 (21) | 122 (79) | 105 (68) | 64 (50) | 18 (14) | 0.85 | 0.72 | |||
| Night time frequency (>0)† | 134 (80) | 92 (55) | 99 (62) | 33 (21) | 126 (82) | 83 (54) | 83 (65) | 24 (19) | 0.75 | 0.82 | |||
| Urgency† | 160 (95) | 139 (83) | 116 (73) | 51 (32) | 149 (97) | 126 (82) | 100 (79) | 42 (33) | 0.54 | 0.88 | |||
| Urge incontinence† | 160 (95) | 160 (95) | 84 (53) | 49 (31) | 148 (96) | 143 (93) | 69 (54) | 43 (34) | 0.82 | 0.65 | |||
| Bladder pain | 84 (50) | 72 (43) | 49 (31) | 29 (18) | 63 (41) | 54 (35) | 36 (28) | 20 (16) | 0.02 | 0.09 | |||
| Stress incontinence† | 168 (100) | 168 (100) | 54 (34) | 35 (22) | 154 (100) | 152 (99) | 37 (29) | 22 (17) | 0.95 | 0.70 | |||
| Unexplained incontinence† | 143 (85) | 139 (83) | 27 (17) | 25 (16) | 129 (84) | 126 (82) | 17 (13) | 17 (13) | 0.90 | 0.88 | |||
| Nocturnal enuresis† | 76 (45) | 72 (43) | 14 (9) | 13 (8) | 72 (47) | 74 (48) | 11 (9) | 9 (7) | 0.90 | 0.29 | |||
| Frequency of incontinent episodes (>never)† | 166 (99) | 166 (99) | 72 (45) | 41 (26) | 154 (100) | 154 (100) | 66 (52) | 32 (25) | 0.55 | 0.17 | |||
| Quantity of urine loss (>none)† | 165 (98) | NA | 70 (44) | NA | 154 (100) | NA | 55 (43) | NA | 0.27 | NA | |||
| Wearing protection† | 161 (96) | NA | 45 (28) | NA | 146 (95) | NA | 30 (24) | NA | 0.68 | 0.17 | |||
| Changing outer clothing† | 139 (83) | NA | 35 (22) | NA | 119 (77) | NA | 37 (29) | NA | 0.15 | NA | |||
| Hesitancy | 57 (34) | 45 (27) | 75 (47) | 13 (21) | 54 (36) | 43 (28) | 70 (55) | 15 (12) | 0.06 | 0.89 | |||
| Straining | 18 (11) | 17 (10) | 25 (16) | 10 (6) | 23 (15) | 23 (15) | 25 (20) | 10 (8) | 0.24 | 0.69 | |||
| Intermittent stream | 67 (40) | 40 (24) | 68 (43) | 10 (6) | 62 (40) | 39 (25) | 69 (54) | 11 (9) | 0.0015 | 0.68 | |||
| Abnormal urinary stream | 66 (39) | 45 (27) | 91 (57) | 17 (11) | 57 (37) | 42 (27) | 86 (68) | 15 (12) | 0.015 | 0.91 | |||
| History of retention | 5 (3) | NA | 8 (5) | NA | 5 (3) | NA | 6 (5) | NA | 0.91 | NA | |||
| Dysuria | 60 (36) | 47 (28) | 38 (24) | 24 (15) | 52 (34) | 39 (25) | 29 (23) | 20 (16) | 0.13 | 0.16 | |||
| Incomplete emptying† | 131 (78) | 104 (62) | 86 (54) | 37 (23) | 114 (74) | 95 (62) | 66 (52) | 28 (22) | 0.84 | 0.93 | |||
| Inability to stop midstream† | 131 (78) | NA | 59 (37) | NA | 120 (78) | NA | 57 (45) | NA | 0.11 | NA | |||
| Sexual questions: | |||||||||||||
| Pain due to dry vagina | 57 (34) | 57 (34) | 51 (32) | 32 (20) | 60 (39) | 54 (36) | 38 (30) | 32 (25) | 0.97 | 0.40 | |||
| Sex life spoilt by symptoms† | 121 (72) | 118 (70) | 49 (31) | 43 (27) | 97 (63) | 95 (62) | 34 (27) | 33 (26) | 0.22 | 0.54 | |||
| Pain with intercourse | 59 (35) | 62 (37) | 38 (24) | 33 (21) | 49 (32) | 46 (30) | 22 (17) | 25 (20) | 0.59 | 0.097 | |||
| Incontinence with intercourse† | 101 (60) | 99 (59) | 22 (14) | 22 (14) | 97 (63) | 91 (59) | 14 (11) | 9 (7) | 0.85 | 0.41 | |||
| Lifestyle questions: | |||||||||||||
| Fluid restriction† | 121 (72) | 99 (59) | 62 (39) | 25 (16) | 109 (71) | 83 (54) | 47 (37) | 14 (11) | 0.78 | 0.72 | |||
| Ability to perform daily tasks† | 136 (81) | 129 (77) | 25 (16) | 21 (13) | 126 (82) | 126 (82) | 19 (15) | 10 (8) | 0.77 | 0.44 | |||
| Avoiding places or situations† | 123 (73) | 121 (72) | 52 (33) | 30 (19) | 114 (74) | 114 (74) | 41 (32) | 28 (22) | 0.82 | 0.96 | |||
| Interfering with physical activity† | 160 (95) | 160 (95) | 32 (20) | 32 (20) | 143 (93) | 140 (91) | 22 (17) | 18 (14) | 0.92 | 0.82 | |||
| Interfering with social relationships† | 121 (72) | 124 (74) | 19 (12) | 21 (13) | 119 (77) | 122 (79) | 17 (13) | 17 (13) | 0.18 | 0.093 | |||
| Interfering with life overall† | 165 (98) | NA | 48 (30) | NA | 145 (94) | NA | 28 (22) | NA | 0.87 | NA | |||
NA=not applicable.
*
Wilcoxon rank sum test, comparing change from baseline to review between two groups.
†
Significant reduction in reporting of symptoms in both groups postoperatively (P<0.0001, Wilcoxon matched pairs test).